Revascularization in renal artery stenosis

Cardiology in Review

Volumn 20, Issue 4, 2012, Pages 189-193

  Foy, Andrew ^a   Ruggiero, Nicholas J ^a   Filippone, Edward J ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

atherosclerotic renal artery stenosis; hypertension; ischemic nephropathy; percutaneous transluminal renal artery angioplasty and stenting; pulmonary edema; renal vascular hypertension; resistant hypertension

Indexed keywords

STATIN;

ANGIOPLASTY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; KIDNEY ARTERY REVASCULARIZATION; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; KIDNEY FUNCTION; LUNG EDEMA; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; REVASCULARIZATION; REVIEW; STENT; SYSTEMATIC REVIEW (TOPIC); TREATMENT INDICATION;

ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION, RENOVASCULAR; ISCHEMIA; KIDNEY; PULMONARY EDEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL ARTERY OBSTRUCTION; REPERFUSION; STENTS;

EID: 84862198180     PISSN: 10615377     EISSN: 15384683     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31824a72e9     Document Type: Review

References (39)

1. Textor SC, Lerman L. Renovascular hypertension and ischemic nephropathy. Am J Hypertens. 2010;23:1159-1169.
2. de Mast Q, Beutler JJ. The prevalence of atherosclerotic renal artery stenosis in risk groups: A systematic literature review. J Hypertens. 2009;27:1333-1340.
3. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: Risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293-301.
4. Hansen KJ, Edwards MS, Craven TE, et al. Prevalence of renovascular disease in the elderly: A population-based study. J Vasc Surg. 2002;36:443-451.
5. Davis RP, Pearce JD, Craven TE, et al. Atherosclerotic renovascular disease among hypertensive adults. J Vasc Surg. 2009;50:564-570, 571.e1.
6. Conlon PJ, Little MA, Pieper K, et al. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60:1490-1497.
7. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
8. Simon G. What is critical renal artery stenosis? Implications for treatment. Am J Hypertens. 2000;13:1189-1193.
9. Rognant N, Guebre-Egziabher F, Bacchetta J, et al. Evolution of renal oxygen content measured by BOLD MRI downstream a chronic renal artery stenosis. Nephrol Dial Transplant. 2011;26:1205-1210.
10. Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med. 2001;344:17-22.
11. Hackam DG, Duong-Hua ML, Mamdani M, et al. Angiotensin inhibition in renovascular disease: A population-based cohort study. Am Heart J. 2008;156:549-555.
12. Isles CG, Robertson S, Hill D. Management of renovascular disease: A review of renal artery stenting in ten studies. QJM. 1999;92:159-167.
13. Gill KS, Fowler RC. Atherosclerotic renal arterial stenosis: Clinical outcomes of stent placement for hypertension and renal failure. Radiology. 2003;226:821-826.
14. Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: A systematic review. Ann Intern Med. 2006;145:901-912.
15. Hansen KJ, Cherr GS, Craven TE, et al. Management of ischemic nephropathy: Dialysis-free survival after surgical repair. J Vasc Surg. 2000;32:472-481; discussion 481.
16. Cherr GS, Hansen KJ, Craven TE, et al. Surgical management of atherosclerotic renovascular disease. J Vasc Surg. 2002;35:236-245.
17. Leertouwer TC, Gussenhoven EJ, Bosch JL, et al. Stent placement for renal arterial stenosis: Where do we stand? A meta-analysis. Radiology. 2000;216:78-85.
18. Bloch MJ, Trost DW, Pickering TG, et al. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens. 1999;12(1 Pt 1):1-7.
19. Gray BH, Olin JW, Childs MB, et al. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med. 2002;7:275-279.
20. Uzzo RG, Novick AC, Goormastic M, et al. Medical versus surgical management of atherosclerotic renal artery stenosis. Transplant Proc. 2002;34:723-725.
21. Balzer KM, Pfeiffer T, Rossbach S, et al. Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD). J Vasc Surg. 2009;49:667-674; discussion 674.
22. Weibull H, Bergqvist D, Bergentz SE, et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study. J Vasc Surg. 1993;18:841-850; discussion 850.
23. van de Ven PJG, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial. Lancet. 1999;353:282-286.
24. Plouin PF, Chatellier G, Darné B, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-829.
25. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens. 1998;12:329-335.
26. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-1014.
27. Bax L, Woittiez AJ, Kouwenberg HJ, et al. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: A randomized trial. Ann Intern Med. 2009;150:840-848, W150.
28. Wheatley K, Ives N, Gray R, et al.; ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953-1962.
29. Nordmann AJ, Woo K, Parkes R, et al. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med. 2003;114:44-50.
30. Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: A meta-analysis of randomized trials. Nephrol Dial Transplant. 2003;18:298-304.
31. Nordmann AJ, Logan AG. Balloon angioplasty versus medical therapy for hypertensive patients with renal artery obstruction. Cochrane Database Syst Rev. 2003;3:CD002944.
32. Kumbhani DJ, Bavry AA, Harvey JE, et al. Clinical outcomes after percutaneous revascularization versus medical management in patients with significant renal artery stenosis: A meta-analysis of randomized controlled trials. Am Heart J. 2011;161:622-630.e1.
33. Krumme B, Hollenbeck M. Doppler sonography in renal artery stenosis-does the Resistive Index predict the success of intervention? Nephrol Dial Transplant. 2007;22:692-696.
34. Ronden RA, Houben AJ, Kessels AG, et al. Predictors of clinical outcome after stent placement in atherosclerotic renal artery stenosis: A systematic review and meta-analysis of prospective studies. J Hypertens. 2010;28:2370-2377.
35. Leesar MA, Varma J, Shapira A, et al. Prediction of hypertension improvement after stenting of renal artery stenosis: Comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J Am Coll Cardiol. 2009;53:2363-2371.
36. Hirsch AT, Haskal ZJ, Hertzer NR, et al.; American Association for Vascular Surgery/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. J Vasc Interv Radiol. 2006;17:1383-1397; quiz 1398.
37. Filippone EJ, Foy A, Newman E. Goal-directed antihypertensive therapy: Lower may not always be better. Cleve Clin J Med. 2011;78:123-133.
38. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood pressure lowering control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575-1585.
39. Ahmed MI, Calhoun DA. Resistant hypertension: Bad and getting worse. Hypertension. 2011;57:1045-1046.